US BANCORP \DE\ - LOGICBIO THERAPEUTICS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of LOGICBIO THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$1,0000.0%2,0000.0%0.00%
Q2 2022$1,0000.0%2,0000.0%0.00%
Q1 2022$1,000
-80.0%
2,0000.0%0.00%
Q4 2021$5,000
-44.4%
2,0000.0%0.00%
Q3 2021$9,0000.0%2,0000.0%0.00%
Q2 2021$9,000
-40.0%
2,0000.0%0.00%
Q1 2021$15,0000.0%2,0000.0%0.00%
Q4 2020$15,000
-16.7%
2,0000.0%0.00%
Q3 2020$18,000
+200.0%
2,000
+166.7%
0.00%
Q2 2020$6,000
+50.0%
7500.0%0.00%
Q1 2020$4,000
-20.0%
7500.0%0.00%
Q4 2019$5,0007500.00%
Other shareholders
LOGICBIO THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 500,000$2,470,0000.65%
Orbimed Advisors 6,466,783$31,946,0000.54%
SAMLYN CAPITAL, LLC 798,566$3,945,0000.10%
ADAGE CAPITAL PARTNERS GP, L.L.C. 915,355$4,522,0000.01%
IHT Wealth Management, LLC 11,660$58,0000.01%
FIDUCIARY TRUST CO 37,998$188,0000.01%
FRANKLIN RESOURCES INC 700,000$3,458,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 13,700$68,0000.00%
Tower Research Capital LLC (TRC) 2,249$11,0000.00%
MANCHESTER FINANCIAL INC 200$1,0000.00%
View complete list of LOGICBIO THERAPEUTICS INC shareholders